Analysis of primary lung tumors and their corresponding metastases revealed identical point mutations affecting p53 in the tumor/metastases pairs in 73% of the cases, suggesting that mutation of p53 is an early event that is essential for tumorigenesis and conserved during progression to metastatic disease[22-24]. This evidence concerns the gene TP53 and lung neoplasm.